A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score
In the non-metastatic BTC group, the cutoff value for the ABIC score was 6.89. The median survival time of patients with a high ABIC score was significantly shorter. In the metastatic BTC group, the cutoff value for the ABIC score was 7.41. Similarly, in this group, patients with a high ABIC score had a significantly shorter median survival time. Additionally, in the non-metastatic BTC group, tumor localization and stage were prognostic factors affecting survival, while in the metastatic BTC group, CEA and first-line chemotherapy were the prognostic factors influencing overall survival. <b>Conclusions:</b> We demonstrate that the ABIC score is a prognostic factor determining median survival in both non-metastatic and metastatic BTC patients.
Authors
- Öznur Bal (ORCID: https://orcid.org/0000-0002-6901-2646)
- Perihan Perkin (ORCID: https://orcid.org/0000-0003-3994-815X)
- Doğan Uncu (ORCID: https://orcid.org/0000-0002-0929-3271)
- Murat Bardakçı (ORCID: https://orcid.org/0000-0001-7854-097X)
- Serhat Sekmek (ORCID: https://orcid.org/0000-0003-4650-248X)
- İsmet Seven (ORCID: https://orcid.org/0009-0001-4706-0495)
- Efnan Algın (ORCID: https://orcid.org/0000-0002-8917-9267)
- Doğan Bayram (ORCID: https://orcid.org/0000-0002-5976-2494)
- Kemal Karaman (ORCID: https://orcid.org/0000-0003-3082-4708)
- Fahriye Tuğba Köş (ORCID: https://orcid.org/0000-0002-6980-4942)
- Derya Demirtaş Esmer
Institutions
- Memorial Ankara Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Current Oncology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.3390/curroncol32040200
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00